Analyst Price Target is $60.50
▼ -3.74% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $60.50, with a high forecast of $69.00 and a low forecast of $52.00. The average price target represents a -3.74% upside from the last price of $62.85.
Current Consensus is
Moderate Buy
The current consensus among 8 polled investment analysts is to moderate buy stock in National Health Investors. This Moderate Buy consensus rating has held steady for over two years.
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More